Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001214659-25-001831
Filing Date
2025-02-04
Accepted
2025-02-04 06:13:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 9236
  Complete submission text file 0001214659-25-001831.txt   11270
Mailing Address 1-4-1, MARUNOUCHI CHIYODA-KU, TOKYO M0 100-8233
Business Address 1-1, SHIBAKOEN, 1-CHOME MINATO-KU, TOKYO M0 105-0011 81-3-6256-6000
Sumitomo Mitsui Trust Group, Inc. (Filed by) CIK: 0001475365 (see all company filings)

EIN.: 000000000 | State of Incorp.: M0
Type: SCHEDULE 13G/A
SIC: 6029 Commercial Banks, NEC
(CF Office: 02 Finance)

Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Subject) CIK: 0001478320 (see all company filings)

EIN.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91363 | Film No.: 25585108
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)